Nasdaq confirms Entero Therapeutics regains compliance with equity rule

GridAI Technologies Corp.

Nasdaq letter dated Oct 28, 2025 confirms company meets $2.5M minimum stockholders' equity requirement.
Company previously reported negative equity of ($3.87M) in 10-K; received extension until Oct 8, 2025.
Compliance achieved via share exchange with GridAI Corp, disclosed in Oct 6, 2025 8-K.
Nasdaq warned that failure to maintain compliance in next periodic report may trigger delisting proceedings.
Company's stock (ENTO) continues trading on Nasdaq Capital Market without immediate delisting risk.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.